Fennec Pharmaceuticals Inc. (TSE:FRX - Get Free Report)'s share price crossed above its 50 day moving average during trading on Friday . The stock has a 50 day moving average of C$9.29 and traded as high as C$9.57. Fennec Pharmaceuticals shares last traded at C$9.57, with a volume of 5,399 shares changing hands.
Fennec Pharmaceuticals Stock Performance
The company has a debt-to-equity ratio of -620.83, a current ratio of 7.80 and a quick ratio of 10.17. The stock's 50-day moving average is C$9.34 and its two-hundred day moving average is C$8.04. The stock has a market cap of C$182.43 million, a P/E ratio of -160.25 and a beta of 0.25.
Insider Activity at Fennec Pharmaceuticals
In other Fennec Pharmaceuticals news, Director Rostislav Christov Raykov sold 10,000 shares of Fennec Pharmaceuticals stock in a transaction on Monday, January 6th. The shares were sold at an average price of C$8.76, for a total value of C$87,552.00. Over the last three months, insiders sold 21,186 shares of company stock valued at $196,017. Insiders own 16.20% of the company's stock.
About Fennec Pharmaceuticals
(
Get Free Report)
Fennec Pharmaceuticals Inc operates as a biopharmaceutical company in the United States. The company's product candidate includes PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patients. It sells its products through regional pediatric oncology specialists and medical science liaisons.
Further Reading
Before you consider Fennec Pharmaceuticals, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Fennec Pharmaceuticals wasn't on the list.
While Fennec Pharmaceuticals currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
